Bessemer Group Inc Axonics, Inc. Transaction History

Bessemer Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $786,340 - $823,959	-11,830 Closed	0 $0
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $761,644 - $932,198	-13,440 Reduced 53.19%	11,830 $816,000
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $312,575 - $403,537	6,330 Added 33.42%	25,270 $1.57 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $454,881 - $584,593	9,352 Added 97.54%	18,940 $1.06 Million
Q2 2023 Aug 10, 2023	BUY	$47.99 - $60.21 $460,128 - $577,293	9,588 New	9,588 $484,000
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $5,158 - $6,952	89 New	89 $6,000
Q4 2021 Jan 27, 2022	SELL	$50.01 - $73.35 $7,151 - $10,489	-143 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $8,467 - $11,248	143 New	143 $9,000

235

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.